257
Views
8
CrossRef citations to date
0
Altmetric
Articles

Myofibroblast keratinocyte growth factor reduces tight junctional integrity and increases claudin-2 levels in polarized Caco-2 cells

, , , , , & show all
Pages 320-332 | Received 14 May 2012, Accepted 27 Jul 2012, Published online: 05 Sep 2012

References

  • Amasheh S, Meiri N, Gitter AH, Schoneberg T, Mankertz J, Schulzke JD, Fromm M. 2002. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci. 115:4969–4976.
  • Amasheh M, Fromm A, Krug SM, Amasheh S, Andres S, Zeitz M, Fromm M, Schulzke JD. 2010. TNFα-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFκB signaling. J Cell Sci. 123:4145–4155.
  • Anderson JM. 2001. Molecular structure of tight junctions and their role in epithelial transport. News Physiol Sci. 16:126–130.
  • Angelow S, Ahlstrom R, Yu AS. 2008. Biology of claudins. Am J Physiol Renal Physiol. 295:F867–F876.
  • Bajaj-Elliott M, Breese E, Poulsom R, Fairclough PD, MacDonald TT. 1997. Keratinocyte growth factor in inflammatory bowel disease. Increased mRNA transcripts in ulcerative colitis compared with Crohn's disease in biopsies and isolated mucosal myofibroblasts. Am J Pathol. 151:1469–1476.
  • Bajaj-Elliott M, Pender SL, Poulsom R, Macdonald TT. Upregulation of keratinocyte growth factor during T-cell immunity in the gut mucosa. Ann NY Acad Sci. 1998a; 859:184–187.
  • Bajaj-Elliott M, Poulsom R, Pender SL, Wathen NC, MacDonald TT. Interactions between stromal cell-derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. J Clin Invest. 1998b; 102:1473–1480.
  • Balda MS, Matter K. 2009. Tight junctions and the regulation of gene expression. Biochim Biophys Acta. 1788:761–767.
  • Bhowmick NA, Neilson EG, Moses HL. 2004. Stromal fibroblasts in cancer initiation and progression. Nature. 432:332–337.
  • Boismenu R, Havran WL. 1994. Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science. 266:1253–1255.
  • Brauchle M, Angermeyer K, Hubner G, Werner S. 1994. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene. 9:3199–3204.
  • Brauchle M, Madlener M, Wagner AD, Angermeyer K, Lauer U, Hofschneider PH, Gregor M, Werner S. 1996. Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am J Pathol. 149:521–529.
  • Buchert M, Papin M, Bonnans C, Darido C, Raye WS, Garambois V, Pelegrin A, Bourgaux JF, Pannequin J, Joubert D, Hollande F. 2010. Symplekin promotes tumorigenicity by up-regulating claudin-2 expression. Proc Natl Acad Sci USA. 107:2628–2633.
  • Bücker R, Schumann M, Amasheh S, Schulzke J-D. 2010. Claudins in intestinal function and disease. Current Topics in Membranes. 65:195–227.
  • Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A. 1988. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res. 48:1936–1942.
  • Chedid M, Rubin JS, Csaky KG, Aaronson SA. 1994. Regulation of keratinocyte growth factor gene expression by interleukin 1. J Biol Chem. 269:10753–10757.
  • Chen Y, Chou K, Fuchs E, Havran WL, Boismenu R. 2002. Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proc Natl Acad Sci USA. 99:14338–14343.
  • Chiba H, Osanai M, Murata M, Kojima T, Sawada N. 2008. Transmembrane proteins of tight junctions. Biochim Biophys Acta. 1778:588–600.
  • Colegio OR, Van Itallie C, Rahner C, Anderson JM. 2003. Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am J Physiol Cell Physiol. 284:C1346–C1354.
  • Cutler NS, Graves-Deal R, LaFleur BJ, Gao Z, Boman BM, Whitehead RH, Terry E, Morrow JD, Coffey RJ. 2003. Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells. Cancer Res. 63:1748–1751.
  • Damstrup L, Kuwada SK, Dempsey PJ, Brown CL, Hawkey CJ, Poulsen HS, Wiley HS, Coffey RJJr. 1999. Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis. Br J Cancer. 80:1012–1019.
  • Denker BM, Nigam SK. 1998. Molecular structure and assembly of the tight junction. Am J Physiol. 274:F1–F9.
  • Dhawan P, Ahmad R, Chaturvedi R, Smith JJ, Midha R, Mittal MK, Krishnan M, Chen X, Eschrich S, Yeatman TJ, Harris RC, Washington MK, Wilson KT, Beauchamp RD, Singh AB. 2011. Claudin-2 expression increases tumorigenicity of colon cancer cells: Role of epidermal growth factor receptor activation. Oncogene. 30:3234–3247.
  • Dlugosz AA, Cheng C, Denning MF, Dempsey PJ, Coffey RJJr, Yuspa SH. 1994. Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes. Cell Growth Differ. 5:1283–1292.
  • Egger B, Procaccino F, Sarosi I, Tolmos J, Buchler MW, Eysselein VE. 1999. Keratinocyte growth factor ameliorates dextran sodium sulfate colitis in mice. Dig Dis Sci. 44:836–844.
  • Enck AH, Berger UV, Yu AS. 2001. Claudin-2 is selectively expressed in proximal nephron in mouse kidney. Am J Physiol Renal Physiol. 281:F966–F974.
  • Escaffit F, Boudreau F, Beaulieu JF. 2005. Differential expression of claudin-2 along the human intestine: Implication of GATA-4 in the maintenance of claudin-2 in differentiating cells. J Cell Physiol. 203:15–26.
  • Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, Yin S, Hill DC, Wiemann B, Starnes CO, Havill AM, Lu ZN, Aukerman SL, Pierce GF, Thomason A, Potten CS, Ulich TR, Lacey DL. 1998. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res. 58:933–939.
  • Finch PW, Cheng AL. 1999. Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease. Gut. 45:848–855.
  • Finch PW, Rubin JS. 2004. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv Cancer Res. 91:69–136.
  • Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA. 1989. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science. 245:752–755.
  • Finch PW, Cunha GR, Rubin JS, Wong J, Ron D. 1995. Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dyn. 203:223–240.
  • Finch PW, Pricolo V, Wu A, Finkelstein SD. 1996. Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease. Gastroenterology. 110:441–451.
  • Furuse M, Sasaki H, Tsukita S. 1999. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol. 147:891–903.
  • Furuse M, Furuse K, Sasaki H, Tsukita S. 2001. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol. 153:263–272.
  • Gonzalez-Mariscal L, Tapia R, Chamorro D. 2008. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta. 1778:729–756.
  • Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Burgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD. 2005. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 129:550–564.
  • Housley RM, Morris CF, Boyle W, Ring B, Biltz R, Tarpley JE, Aukerman SL, Devine PL, Whitehead RH, Pierce F. 1994. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest. 94:1764–1777.
  • Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. 2000. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology. 118:1001–1011.
  • Kiuchi-Saishin Y, Gotoh S, Furuse M, Takasuga A, Tano Y, Tsukita S. 2002. Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol. 13:875–886.
  • Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. 2008. Structure and function of claudins. Biochim Biophys Acta. 1778:631–645.
  • MacDonald TT, Monteleone G, Pender SL. 2000. Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol. 51:2–9.
  • Mankertz J, Amasheh M, Krug SM, Fromm A, Amasheh S, Hillenbrand B, Tavalali S, Fromm M, Schulzke JD. 2009. TNFalpha up-regulates claudin-2 expression in epithelial HT-29/B6 cells via phosphatidylinositol-3-kinase signaling. Cell Tissue Res. 336:67–77.
  • Merchant NB, Rogers CM, Trivedi B, Morrow J, Coffey RJ. 2005. Ligand-dependent activation of the epidermal growth factor receptor by secondary bile acids in polarizing colon cancer cells. Surgery. 138:415–421.
  • Merchant NB, Voskresensky I, Rogers CM, Lafleur B, Dempsey PJ, Graves-Deal R, Revetta F, Foutch AC, Rothenberg ML, Washington MK, Coffey RJ. 2008. TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer. Clin Cancer Res. 14:1182–1191.
  • Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM, Aaronson SA. 1992. Determination of ligand-binding specificity by alternative splicing: Two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA. 89:246–250.
  • Mineta K, Yamamoto Y, Yamazaki Y, Tanaka H, Tada Y, Saito K, Tamura A, Igarashi M, Endo T, Takeuchi K, Tsukita S. 2011. Predicted expansion of the claudin multigene family. FEBS Lett. 585:606–612.
  • Piepkorn M, Underwood RA, Henneman C, Smith LT. 1995. Expression of amphiregulin is regulated in cultured human keratinocytes and in developing fetal skin. J Invest Dermatol. 105:802–809.
  • Piontek J, Winkler L, Wolburg H, Muller SL, Zuleger N, Piehl C, Wiesner B, Krause G, Blasig IE. 2008. Formation of tight junction: Determinants of homophilic interaction between classic claudins. FASEB J. 22:146–158.
  • Potten CS, O'Shea JA, Farrell CL, Rex K, Booth C. 2001. The effects of repeated doses of keratinocyte growth factor on cell proliferation in the cellular hierarchy of the crypts of the murine small intestine. Cell Growth Differ. 12:265–275.
  • Powell DW. 1981. Barrier function of epithelia. Am J Physiol. 241:G275–G288.
  • Powell DW. 2000. Myofibroblasts: Paracrine cells important in health and disease. Trans Am Clin Climatol Assoc. 111 271–292: 271–293.
  • Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol. 1999a; 277:C1–C9.
  • Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol. 1999b; 277:C183–C201.
  • Powell DW, Adegboyega PA, Di Mari JF, Mifflin RC. 2005. Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer. Am J Physiol Gastrointest Liver Physiol. 289:G2–G7.
  • Prasad S, Mingrino R, Kaukinen K, Hayes KL, Powell RM, MacDonald TT, Collins JE. 2005. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest. 85:1139–1162.
  • Rosenthal R, Milatz S, Krug SM, Oelrich B, Schulzke JD, Amasheh S, Gunzel D, Fromm M. 2010. Claudin-2, a component of the tight junction, forms a paracellular water channel. J Cell Sci. 123:1913–1921.
  • Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA. 1989. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA. 86:802–806.
  • Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. 2005. The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 21:1–26.
  • Schneeberger EE, Lynch RD. 2004. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol. 286:C1213–C1228.
  • Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, Richter J, Bojarski C, Schumann M, Fromm M. 2009. Epithelial tight junctions in intestinal inflammation. Ann NY Acad Sci. 1165:294–300.
  • Shao J, Sheng GG, Mifflin RC, Powell DW, Sheng H. 2006. Roles of myofibroblasts in prostaglandin E2-stimulated intestinal epithelial proliferation and angiogenesis. Cancer Res. 66:846–855.
  • Suzuki T, Yoshinaga N, Tanabe S. 2011. Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem. 286:31263–31271.
  • Takehara M, Nishimura T, Mima S, Hoshino T, Mizushima T. 2009. Effect of claudin expression on paracellular permeability, migration and invasion of colonic cancer cells. Biol Pharm Bull. 32:825–831.
  • Thorne BA, Plowman GD. 1994. The heparin-binding domain of amphiregulin necessitates the precursor pro-region for growth factor secretion. Mol Cell Biol. 14:1635–1646.
  • Valentich JD, Popov V, Saada JI, Powell DW. 1997. Phenotypic characterization of an intestinal subepithelial myofibroblast cell line. Am J Physiol. 272:C1513–C1524.
  • Van Itallie CM, Anderson JM. The molecular physiology of tight junction pores. Physiology (Bethesda). 2004a; 19:331–338.
  • Van Itallie CM, Anderson JM. The role of claudins in determining paracellular charge selectivity. Proc Am Thorac Soc. 2004b; 1:38–41.
  • Van Itallie CM, Fanning AS, Anderson JM. 2003. Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am J Physiol Renal Physiol. 285:F1078–F1084.
  • Van Itallie CM, Mitic LL, Anderson JM. 2011. Claudin-2 forms homodimers and is a component of a high molecular weight protein complex. J Biol Chem. 286:3442–3450.
  • Visco V, Bava FA, d'Alessandro F, Cavallini M, Ziparo V, Torrisi MR. 2009. Human colon fibroblasts induce differentiation and proliferation of intestinal epithelial cells through the direct paracrine action of keratinocyte growth factor. J Cell Physiol. 220:204–213.
  • Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. 2008. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 88:1110–1120.
  • Wisner DM, Harris LRIII, Green CL, Poritz LS. 2008. Opposing regulation of the tight junction protein claudin-2 by interferon-gamma and interleukin-4. J Surg Res. 144:1–7.
  • Yang H, Antony PA, Wildhaber BE, Teitelbaum DH. 2004. Intestinal intraepithelial lymphocyte gamma delta-T cell-derived keratinocyte growth factor modulates epithelial growth in the mouse. J Immunol. 172:4151–4158.
  • Zeeh JM, Procaccino F, Hoffmann P, Aukerman SL, McRoberts JA, Soltani S, Pierce GF, Lakshmanan J, Lacey D, Eysselein VE. 1996. Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology. 110:1077–1083.
  • Zeissig S, Burgel N, Gunzel D, Richter J, Mankertz J, Wahnschaffe U, Kroesen AJ, Zeitz M, Fromm M, Schulzke JD. 2007. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut. 56:61–72.
  • Zigrino P, Loffek S, Mauch C. 2005. Tumor-stroma interactions: Their role in the control of tumor cell invasion. Biochimie. 87:321–328.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.